Suchan Kim

FDA investigator

Appears on 7 documents from 2024 to 2026, mostly at sites in New Jersey. Most often cites responsibilities of quality control unit (21 CFR 211.22(a)).

7
Documents on file
5.4
Observations per 483
2024
First seen
2026
Most recent

What they cite most

From 38 observations

Activity by year

2024: 3, 2025: 3, 2026: 1

Where

New Jersey 7

Is Suchan Kim coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

7 documents, newest first
FirmOpen
483 Safrel Pharmaceuticals LLCJan 30, 2026 · Dayton, New Jersey
483 Acino Products, LLCMay 21, 2025 · Hamilton, New Jersey
483 Everest Life Sciences LLCApr 23, 2025 · PLAINSBORO, New Jersey
483 Tulex Pharmaceuticals IncMar 24, 2025 · Cranbury, New Jersey
483 Cosmetic Essence, LLC dba Voyant BeautyDec 6, 2024 · Ridgefield, New Jersey
483 Salvona Technologies, LLCOct 18, 2024 · Hamilton, New Jersey
483 Health Pharma USA LLCJul 3, 2024 · Rahway, New Jersey

About this profile

What does Suchan Kim inspect?

Suchan Kim appears on 7 documents on file covering 7 sites, mostly in New Jersey.

What do they cite most often?

21 CFR 211.22(a) (responsibilities of quality control unit), followed by 21 CFR 211.100(a) and 21 CFR 211.160(b).

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Suchan Kim is dated Jan 30, 2026.